Saccharomyces cerevisiae biomass as a source of next-generation food preservatives: Evaluating potential proteins as a source of antimicrobial peptides.
- 2021-08-11
- Comprehensive Reviews in Food Science and Food Safety 20(5)
- P. Pereira
- C. S. Freitas
- V. Paschoalin
- PubMed: 34378312
- DOI: 10.1111/1541-4337.12798
Abstract
Saccharomyces cerevisiae is the main biotechnological tool for the production of Baker's or Brewer's biomasses, largely applied in beverage and fermented-food production. Through its gene expression reprogramming and production of compounds that inactivate the growth of other microorganisms, S. cerevisiae is able to grow in adverse environments and in complex microbial consortia, as in fruit pulps and root flour fermentations. The distinct set of up-regulated genes throughout yeast biomass propagation includes those involved in sugar fermentation, ethanol metabolization, and in protective responses against abiotic stresses. These high abundant proteins are precursors of several peptides with promising health-beneficial activities such as antihypertensive, antioxidant, antimicrobial, immunomodulatory, anti-obesity, antidiabetes, and mitogenic properties. An in silico investigation of these S. cerevisiae derived peptides produced during yeast biomass propagation or induced by physicochemical treatments were performed using four algorithms to predict antimicrobial candidates encrypted in abundantly expressed stress-related proteins encoded by different genes like AHP1, TSA1, HSP26, SOD1, HSP10, and UTR2, or metabolic enzymes involved in carbon source utilization, like ENO1/2, TDH1/2/3, ADH1/2, FBA1, and PDC1. Glyceraldehyde-3-phosphate dehydrogenase and enolase II are noteworthy precursor proteins, since they exhibited the highest scores concerning the release of antimicrobial peptide candidates. Considering the set of genes upregulated during biomass propagation, we conclude that S. cerevisiae biomass, a food-grade product consumed and marketed worldwide, should be considered a safe and nonseasonal source for designing next-generation bioactive agents, especially protein encrypting antimicrobial peptides that display broad spectra activity and could reduce the emergence of microbial resistance while also avoiding cytotoxicity.
Keywords: GAPDH and enolase II; GRAS antimicrobial peptides; abiotic stresses; food safety and preservation; yeast biomass.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Saccharomyces cerevisiae | Enhanced Antimicrobial Resistance | Beneficial | Large |
Saccharomyces cerevisiae | Improved Immunomodulation | Beneficial | Moderate |
Saccharomyces cerevisiae | Increased Antioxidant Activity | Beneficial | Moderate |
Saccharomyces cerevisiae | Increased Mitogenic Activity | Beneficial | Moderate |
Saccharomyces cerevisiae | Reduced Glucose Levels | Beneficial | Moderate |
Saccharomyces cerevisiae | Reduced Hypertension | Beneficial | Moderate |
Saccharomyces cerevisiae | Reduced Obesity | Beneficial | Moderate |
Saccharomyces cerevisiae fermentate | Improved Immunomodulation | Beneficial | Moderate |
Saccharomyces cerevisiae fermentate | Increased Antioxidant Activity | Beneficial | Moderate |
Saccharomyces cerevisiae fermentate | Increased Cell Division | Beneficial | Moderate |
Saccharomyces cerevisiae fermentate | Reduced Blood Pressure | Beneficial | Moderate |
Saccharomyces cerevisiae fermentate | Reduced Obesity | Beneficial | Moderate |
Saccharomyces cerevisiae fermentate | Reduced Risk of Antimicrobial Resistance | Beneficial | Large |
Saccharomyces cerevisiae fermentate | Reduced Risk of Diabetes | Beneficial | Moderate |